NCT05941195 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Gözüm S, Aksayan S
Öz-etkililik-yeterlik ölçegi'nin türkçe formunun güvenilirlik ve geçerliligi. Anadolu Hemsirelik ve Saglik Bilimleri Dergisi. 1999; 2(1): 21-34.
Ögel K, Koç C, Basabak A, Ismen EM, Görücü S
Bagimlilik profil indeksi klinik formunun (BAPI-K) gelistirilmesi: Geçerlik ve güvenilirlik Çalismasi. Bagimlilik Dergisi.2015; 16(2), 57-69.
Sherer M, Maddux JE, Mercandante B, Prentice-Dunn S, Jacobs B, Rogers R W
The self-efficacy scale: Construction and validation. Psychological reports.1982; 51(2), 663-671.
Simsek M, Dinc M, Ogel K
The Validity aand Reliability of the Addiction Outcome Assessment Index (AOAI). Turk Psikiyatri Derg. 2021 Summer;32(2):129-136. doi: 10.5080/u23461. English, Turkish.

Investigation of the Effect of Cognitive Behavioral Approach-Based Psychoeducation on Addiction Profile, Self-efficacy and Addiction Course in Substance Use Disorder Randomized Controlled Experimental Study

Details for clinical trial NCT05941195

Clinical trial NCT05941195 - References